EUVIMEDEUVIMED entdecken
Crossref

Pit 1 transporter (SLC20A1) as a key factor in the NPP1‐mediated inhibition of insulin signaling in human podocytes

Tomasz Kulesza iD, Marlena Typiak, Patrycja Rachubik iD, Dorota Rogacka iD, Irena Audzeyenka, Moin A Saleem, Agnieszka Piwkowska iD

Journal of Cellular Physiology · 2023

DOI: 10.1002/jcp.31051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2023. Verfasst von Tomasz Kulesza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular and Cellular Nephrology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Gdansk, Poland. Hauptthemen laut MEDLINE: Podocytes, Insulin Resistance, Diabetic Nephropathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Podocytes are crucially involved in blood filtration in the glomerulus. Their proper function relies on efficient insulin responsiveness. The insulin resistance of podocytes, defined as a reduction of cell sensitivity to this hormone, is the earliest pathomechanism of microalbuminuria that is observed in metabolic syndrome and diabetic nephropathy. In many tissues, this alteration is mediated by the phosphate homeostasis‐controlling enzyme nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1). By binding to the insulin receptor (IR), NPP1 inhibits downstream cellular signaling. Our previous research found that hyperglycemic conditions affect another protein that is involved in phosphate balance, type III sodium‐dependent phosphate transporter 1 (Pit 1). In the present study, we evaluated the insulin resistance of podocytes after 24 h of incubation under hyperinsulinemic conditions. Thereafter, insulin signaling was inhibited. The formation of NPP1/IR complexes was observed at that time. A novel finding in the present study was our observation of an interaction between NPP1 and Pit 1 after the 24 h stimulation of podocytes with insulin. After downregulation of the SLC20A1 gene, which encodes Pit 1, we established insulin resistance in podocytes that were cultured under native conditions, manifested as a lack of intracellular insulin signaling and the inhibition of glucose uptake via the glucose transporter type 4. These findings suggest that Pit 1 might be a major factor that participates in the NPP1‐mediated inhibition of insulin signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PodocytesInsulin ResistanceDiabetic NephropathiesHumansInsulinPhosphoric Diester HydrolasesPhosphatesGlucoseSodium-Phosphate Cotransporter Proteins, Type IIIPyrophosphatases

Stichwörter der Autor:innen

diabetic nephropathyinsulin resistanceinsulin signalingphosphate transporterspodocyte

Substanzen

InsulinPhosphoric Diester HydrolasesPhosphatesGlucoseSodium-Phosphate Cotransporter Proteins, Type IIInucleotide pyrophosphatasePyrophosphatasesSLC20A1 protein, human

Autor:innen und Institutionen

  • Laboratory of Molecular and Cellular Nephrology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Gdansk, Poland.
  • Department of General and Medical Biochemistry, Faculty of Biology, University of Gdansk, Gdansk, Poland.
  • Department of Molecular Biotechnology, Faculty of Chemistry, University of Gdansk, Gdansk, Poland.
  • Bristol Renal, University of Bristol, Bristol, UK.

ORCID-Profile: Tomasz Kulesza, Patrycja Rachubik, Dorota Rogacka, Agnieszka Piwkowska

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Kulesza, T., Typiak, M., Rachubik, P., Rogacka, D., Audzeyenka, I., Saleem, M. A., & Piwkowska, A. (2023). Pit 1 transporter (SLC20A1) as a key factor in the NPP1‐mediated inhibition of insulin signaling in human podocytes. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31051

Vancouver

Kulesza T, Typiak M, Rachubik P, Rogacka D, Audzeyenka I, Saleem MA, et al. Pit 1 transporter (SLC20A1) as a key factor in the NPP1‐mediated inhibition of insulin signaling in human podocytes. Journal of Cellular Physiology. 2023. doi:10.1002/jcp.31051

BibTeX
@article{Kulesza2023,
  author = {Kulesza, Tomasz and Typiak, Marlena and Rachubik, Patrycja and Rogacka, Dorota and Audzeyenka, Irena and Saleem, Moin A and Piwkowska, Agnieszka},
  title = {Pit 1 transporter (SLC20A1) as a key factor in the NPP1‐mediated inhibition of insulin signaling in human podocytes},
  journal = {Journal of Cellular Physiology},
  year = {2023},
  doi = {10.1002/jcp.31051}
}
Kostenlos starten →